AAIPharma, Inc. completed more than $2 million in upgrades to its parenteral manufacturing facility in Charleston, SC and its sterile product release operation in Wilmington, NC. The improvements were made to increase capacity and to help ensure compliance with EU aseptic processing and testing guidelines for products exported to the EU. Lee Karras, AAIPharma’s senior vice president of North American pharmaceutical operations, remarked, “By making this investment, we have made a...